Biotricity is trading 8.6% down at $0.05 on October 12, 2026, with no clear company-specific announcement or reliable report explaining the decline. - The company’s news page lists no October 12 catalyst. - Available market context is mixed and does not establish a broader-market explanation. - A director resignation was reported as effective September 22, but the available filing does not connect it to this session’s decline.